Hemp CBD Science
  • Home
  • About Us
    • About Us
    • Key Opinion Leaders
    • About the Endocannabinoid System
      • Cannabis
      • Cannabidiol (CBD)
      • The Endocannabinoid system
      • Endocannabinoid Deficiency
  • Disorders
    • Autoimmune Disorders
      • Rheumatoid Arthritis
      • Crohn’s Disease
      • Multiple Sclerosis
      • Chronic Autoimmune Myocarditis
      • Autoimmune Encephalomyelitis
    • Cancer-Related Symptoms
      • Pain
      • Anti Nausea
      • Appetite Stimulation
    • Neuroprotection
      • Chronic Traumatic Encephalopathy
      • Hepatic Encephalopathy
      • Parkinson’s Disease
      • Alzheimer’s/Dementia
      • Alcohol-Related Neurotoxicity
      • Epilepsy
    • Anxiety Disorders
      • Generalized Anxiety Disorder (GAD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Social Anxiety Disorder (SAD)
      • Obsessive–compulsive disorder (OCD)
    • Cancer
      • Glioblastoma
      • Leukemia
      • Colorectal
      • Lung Cancer
      • Cervical cancer
      • Prostate Cancer
      • Melanoma
      • Breast Cancer
    • Gastrointestinal
      • Inflammatory Bowel Disease
      • Irritable Bowel Syndrome
      • Ulcerative Colitis
      • Crohn’s Disease
    • Sleep
      • Insomnia
    • Pain
      • Joint Pain
      • Neuropathic Pain
      • Acute Pain
      • Chronic Pain
  • Participate
    • Our Ongoing Study
    • Current Clinical Trials
    • Equine Study
      • Equine Study Enter Your Data
  • Videos
  • Research Blog
    • Science
    • News
    • Legal
  • Physician Guide
    • Dosing Suggestions
    • State Medical Board Guide
    • Safety, Side Effects & Drug Interactions
  • Contact
Select Page

Research on CBD for Melanoma

(2017)        Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 

(2015)       Differential role of cannabinoids in the pathogenesis of skin cancer.

(2015)        Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death.

(2014)        CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier. 

(2013)        Anticancer activity of anandamide in human cutaneous melanoma cells. 

(2012)        Cannabinoid receptor 2 is upregulated in melanoma.

(2012)        Revisiting CB1 receptor as drug target in human melanoma. 

 

Recent Posts

  • Why You Should Consider Medical-Grade Dry-Herb Vapes
  • August 28th: Anniversary of When Bob Dylan Introduced The Beatles to Cannabis
  • Does “low dose” CBD pose a risk to liver health?
  • Remembering Wade Laughter, the Unsung Hero of CBD
  • CBD Topical Medicine: What Does the Science Say?

Categories

  • Legal
  • News
  • Science
  • Uncategorized

* The information is presented for educational purposes only. Hemp CBD Science provides this information to provide an understanding of the potential applications of cannabinoids. Links to third party websites do not constitute an endorsement of these organizations by us and none should be inferred. These statements have not been evaluated by the Food and Drug Administration. These products featured on this site are not intended to diagnose, treat, cure or prevent any disease. Consult your physician before beginning any exercise program. Please view our Privacy Policy for more information. Copyright, Hemp CBD Science. If you believe your have a copyright claim, click here. Material on Hemp CBD Science may not be reprinted without permission.

  • Facebook
  • X
© 2017 Hemp CBD Science. All Rights Reserved. Privacy Policy. Copyright Information.